UBS · VRTX Holdings Trend
Vertex Pharmaceuticals · SEC 13F
UBS Holdings of VRTX by Quarter
Quarter Shares Value
| Quarter | Shares | Value | QoQ Change |
|---|---|---|---|
| 2024Q1 | 3.1M | $1.3B | — |
| 2024Q2 | 3.8M | $1.5B | +19.6% |
| 2024Q3 | 3.8M | $1.5B | +0.6% |
| 2024Q4 | 4.0M | $1.3B | -12.5% |
| 2025Q1 | 4.4M | $1.6B | +22.9% |
| 2025Q2 | 5.0M | $1.7B | +5.2% |
| 2025Q3 | 5.7M | $1.5B | -13.7% |
| 2025Q4 | 9.6M | $1.7B | +16.7% |
| 2026Q1 | 9.3M | $1.7B | -1.1% |
← Back to VRTX holders ← Back to VRTX profile
Data source: SEC EDGAR Form 13F